ASH Comments for the Cell and Gene Therapy Access Model for Sickle Cell Disease
Nov 03
2023
91国产精品. (2023).
ASH Comments for the Cell and Gene Therapy Access Model for Sickle Cell Disease.
Retrieved from /advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-comments-for-the-cell-and-gene-therapy-access-model-for-sickle-cell-disease.
91国产精品.
"ASH Comments for the Cell and Gene Therapy Access Model for Sickle Cell Disease." Hematology.org.
/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-comments-for-the-cell-and-gene-therapy-access-model-for-sickle-cell-disease
(label-accessed November 14, 2024).
"91国产精品."
ASH Comments for the Cell and Gene Therapy Access Model for Sickle Cell Disease, 14 Nov. 2024 ,
/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-comments-for-the-cell-and-gene-therapy-access-model-for-sickle-cell-disease.
